Home › NDC Lookup › RxCUI directory › RxCUI 637173

Cephalexin 750 MG Oral Capsule — RxCUI 637173

RxNorm drug concept · Semantic clinical drug
RxCUI 637173 Semantic clinical drug · SCD ● Current RxNorm concept 14 FDA products 36 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI637173
Official nameCephalexin 750 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped14
Package NDCs mapped36
Reported Medicaid activity (SDUD)906,978 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Cephalexin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Cephalexin is an antibiotic used to treat bacterial infections — things like strep throat and other respiratory infections, ear infections, skin infections, bone infections, and ur...
  • Yes, you can take cephalexin with or without food — it's stable in stomach acid either way. If it upsets your stomach, taking it with a small meal or snack can help. Just try to ta...
  • The most common side effects are stomach-related — diarrhea, nausea, vomiting, or indigestion. These are usually mild and manageable. The ones to call your doctor about are: a seve...
  • What side effects should I watch out for?
📖 Read our full Cephalexin guide →

🕸️ Concept Web — How Cephalexin 750 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Cephalexin 750 MG Oral Capsule RxCUI 637173

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Cephalexin 2231
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Cephalexin Oral Capsule 371345
    • Cephalexin Oral Product 1152430
    • Cephalexin Pill 1152431
    • Oral Capsule 316965
    • Oral Product 1151131
    • Pill 1151133
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Cephalexin 750 MG 637172

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Cephalexin 750 MG SCDC · 637172
  • Cephalexin Oral Capsule SCDF · 371345
  • Cephalexin Oral Product SCDG · 1152430
  • Cephalexin Pill SCDG · 1152431

📦 FDA Products & Package NDCs

14 products · 36 package NDCs
36 package NDCs map to RxCUI 637173 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
59651-0728-20 20 CAPSULE in 1 BOTTLE (59651-728-20) Cephalexin Aurobindo Pharma Limited 2023-12-06
59651-0728-50 50 CAPSULE in 1 BOTTLE (59651-728-50) Cephalexin Aurobindo Pharma Limited 2023-12-06
63629-9202-01 20 CAPSULE in 1 BOTTLE (63629-9202-1) Cephalexin Bryant Ranch Prepack 2012-06-04
63629-9203-01 50 CAPSULE in 1 BOTTLE (63629-9203-1) Cephalexin Bryant Ranch Prepack 2012-06-04
63629-9435-01 20 CAPSULE in 1 BOTTLE (63629-9435-1) Cephalexin Bryant Ranch Prepack 2022-09-09
63629-9436-01 50 CAPSULE in 1 BOTTLE (63629-9436-1) Cephalexin Bryant Ranch Prepack 2022-09-09
67877-0219-01 100 CAPSULE in 1 BOTTLE (67877-219-01) Cephalexin Ascend Laboratories, LLC 2011-01-19
67877-0219-05 500 CAPSULE in 1 BOTTLE (67877-219-05) Cephalexin Ascend Laboratories, LLC 2011-01-19
67877-0219-10 1000 CAPSULE in 1 BOTTLE (67877-219-10) Cephalexin Ascend Laboratories, LLC 2011-01-19
67877-0219-20 20 CAPSULE in 1 BOTTLE (67877-219-20) Cephalexin Ascend Laboratories, LLC 2011-01-19
67877-0219-38 100 BLISTER PACK in 1 CARTON (67877-219-38) / 1 CAPSULE in... Cephalexin Ascend Laboratories, LLC 2011-01-19
67877-0219-74 50 BLISTER PACK in 1 CARTON (67877-219-74) / 1 CAPSULE in 1... Cephalexin Ascend Laboratories, LLC 2011-01-19
67877-0219-84 30 BLISTER PACK in 1 CARTON (67877-219-84) / 1 CAPSULE in 1... Cephalexin Ascend Laboratories, LLC 2011-01-19
67877-0220-01 100 CAPSULE in 1 BOTTLE (67877-220-01) Cephalexin Ascend Laboratories, LLC 2011-01-20
67877-0220-05 500 CAPSULE in 1 BOTTLE (67877-220-05) Cephalexin Ascend Laboratories, LLC 2011-01-20
67877-0220-10 1000 CAPSULE in 1 BOTTLE (67877-220-10) Cephalexin Ascend Laboratories, LLC 2011-01-20
67877-0220-20 20 CAPSULE in 1 BOTTLE (67877-220-20) Cephalexin Ascend Laboratories, LLC 2011-01-20
67877-0220-38 100 BLISTER PACK in 1 CARTON (67877-220-38) / 1 CAPSULE in... Cephalexin Ascend Laboratories, LLC 2011-01-20
67877-0220-74 50 BLISTER PACK in 1 CARTON (67877-220-74) / 1 CAPSULE in 1... Cephalexin Ascend Laboratories, LLC 2011-01-20
67877-0220-84 30 BLISTER PACK in 1 CARTON (67877-220-84) / 1 CAPSULE in 1... Cephalexin Ascend Laboratories, LLC 2011-01-20
67877-0254-01 100 CAPSULE in 1 BOTTLE (67877-254-01) Cephalexin Ascend Laboratories, LLC 2012-06-04
67877-0254-05 500 CAPSULE in 1 BOTTLE (67877-254-05) Cephalexin Ascend Laboratories, LLC 2012-06-04
67877-0254-10 1000 CAPSULE in 1 BOTTLE (67877-254-10) Cephalexin Ascend Laboratories, LLC 2012-06-04
67877-0254-20 20 CAPSULE in 1 BOTTLE (67877-254-20) Cephalexin Ascend Laboratories, LLC 2012-06-04
67877-0254-38 100 BLISTER PACK in 1 CARTON (67877-254-38) / 1 CAPSULE in... Cephalexin Ascend Laboratories, LLC 2012-06-04
67877-0255-01 100 CAPSULE in 1 BOTTLE (67877-255-01) Cephalexin Ascend Laboratories, LLC 2012-06-04
67877-0255-05 500 CAPSULE in 1 BOTTLE (67877-255-05) Cephalexin Ascend Laboratories, LLC 2012-06-04
67877-0255-10 1000 CAPSULE in 1 BOTTLE (67877-255-10) Cephalexin Ascend Laboratories, LLC 2012-06-04
67877-0255-20 20 CAPSULE in 1 BOTTLE (67877-255-20) Cephalexin Ascend Laboratories, LLC 2012-06-04
67877-0255-23 50 CAPSULE in 1 BOTTLE (67877-255-23) Cephalexin Ascend Laboratories, LLC 2012-06-04
72162-1833-02 50 CAPSULE in 1 BOTTLE (72162-1833-2) Cephalexin Bryant Ranch Prepack 2023-04-18
72162-1833-04 20 CAPSULE in 1 BOTTLE (72162-1833-4) Cephalexin Bryant Ranch Prepack 2023-04-18
76420-0592-10 100 CAPSULE in 1 BOTTLE (76420-592-10) Cephalexin Asclemed USA, Inc. 2023-09-01
76420-0593-10 100 CAPSULE in 1 BOTTLE (76420-593-10) Cephalexin Asclemed USA, Inc. 2023-09-01
76420-0594-10 100 CAPSULE in 1 BOTTLE (76420-594-10) Cephalexin Asclemed USA, Inc. 2023-09-01
76420-0595-10 100 CAPSULE in 1 BOTTLE (76420-595-10) Cephalexin Asclemed USA, Inc. 2023-09-01
Observed labelers: Ascend Laboratories, LLC (24) · Bryant Ranch Prepack (6) · Asclemed USA, Inc. (4) · Aurobindo Pharma Limited (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.